Re: Clinical Performance of Serum Isoform (-2)proPSA (p2PSA) and its Derivatives, Namely %p2PSA and PHI (Prostate Health Index) in Men Younger than 60 Years of Age: Results from a Multicentric European Study

Samir Taneja

doi:10.1016/j.juro.2014.05.076

Re: Clinical Performance of Serum Isoform (-2)proPSA (p2PSA) and its Derivatives, Namely %p2PSA and PHI (Prostate Health Index) in Men Younger than 60 Years of Age: Results from a Multicentric European Study

Samir Taneja

Biomedical Engineering

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	The Journal of Urology
DOIs	https://doi.org/10.1016/j.juro.2014.05.076
State	Published - 2014

Access to Document

10.1016/j.juro.2014.05.076

Cite this

@article{f4e651ba73be412e974ef8688731bf8b,

title = "Re: Clinical Performance of Serum Isoform (-2)proPSA (p2PSA) and its Derivatives, Namely %p2PSA and PHI (Prostate Health Index) in Men Younger than 60 Years of Age: Results from a Multicentric European Study",

author = "Samir Taneja",

year = "2014",

doi = "10.1016/j.juro.2014.05.076",

language = "English (US)",

journal = "The Journal of Urology",

issn = "0022-5347",

}

TY - JOUR

T1 - Re: Clinical Performance of Serum Isoform (-2)proPSA (p2PSA) and its Derivatives, Namely %p2PSA and PHI (Prostate Health Index) in Men Younger than 60 Years of Age: Results from a Multicentric European Study

AU - Taneja, Samir

PY - 2014

Y1 - 2014

U2 - 10.1016/j.juro.2014.05.076

DO - 10.1016/j.juro.2014.05.076

M3 - Article

SN - 0022-5347

JO - The Journal of Urology

JF - The Journal of Urology

ER -